Cargando…
Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours.
Circulating neuron-specific enolase (NSE) and chromogranin A (CgA) were measured in 128 patients with neuroendocrine tumours (NET) to compare their sensitivity and specificity, to investigate factors associated with elevated serum levels and to determine the usefulness of these markers in the follow...
Autores principales: | Baudin, E., Gigliotti, A., Ducreux, M., Ropers, J., Comoy, E., Sabourin, J. C., Bidart, J. M., Cailleux, A. F., Bonacci, R., Ruffié, P., Schlumberger, M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group|1
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063160/ https://www.ncbi.nlm.nih.gov/pubmed/9792158 |
Ejemplares similares
-
Chromogranin A and the α -subunit of glycoprotein hormones in medullary thyroid carcinoma and phaeochromocytoma
por: Guignat, L, et al.
Publicado: (2001) -
Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin
por: Mitry, E, et al.
Publicado: (1999) -
Cytotoxic therapy with etoposide and cisplatin in advanced adrenocortical carcinoma. Réseau Comète INSERM.
por: Bonacci, R., et al.
Publicado: (1998) -
Clinical significance of progastrin-releasing peptide, neuron-specific enolase, chromogranin a, and squamous cell cancer antigen in pulmonary neuroendocrine tumors
por: TUTAR, Nuri, et al.
Publicado: (2019) -
Ca125 and neuron-specific enolase (NSE) as tumour markers for intra-abdominal desmoplastic small round-cell tumours.
por: Fizazi, K., et al.
Publicado: (1997)